Democritus University of Thrace (DUTH)
Επίπεδα λιποπρωτεΐνης (a) σε παιδιά πριν και μετά τη λήψη αντιβιοτικών φαρμάκων
Abstract
dc:descriptionHigh lipoprotein (a), Lp(a), levels are closely related to thrombosis damage. Aim: The aim of this study was the evaluation of serum Lp(a) levels before and after 10 days treatment with certain antibiotic drugs. Patients and Methods: Before the beginning of this study, 3298 Lp(a) values were analyzed according to age percentiles (6-14 yrs) in order to establish control values. 110 children 6-14 yrs old, mean age 10±4 yrs were enrolled in this study. The children were admitted to the outpatient department of a pediatric Hospital in Athens because of fever (>380 C) during the last 3 days. Blood was obtained before and ten days after treatment for common laboratory tests (complete blood counts SG0T, SGPT etc.) as well as for Lp(a) estimation with an immunoassay. Children were divided into groups according to their antibiotic treatment. - Group A (n=24) received 40mg/kg BW/24h of amoxicillin/ clavulanic acid - Group B (n=25) received 40mg/kg BW/24h of cefaclor - Group C (n=22) received 30mg/kg BW/24h of loracarbef - Group D (n=19) received 06mg/kg BW/24h of trimethoprim/sulfamethoxazole and - Group E (n=20) received 15mg/kg BW/24h of clarithromycin Results: Remarkable increase in Lp(a) levels was observed in all groups ten days after treatment with one of the above mentioned antibiotics, except Group B, whereas the other biochemical parameters did not show any significant difference. In addition, Lp(a) levels pre vs. post therapy are presented in detail: Group A pre 105.5±15 vs 174±10 (p<0.001) Group C pre 102±10 vs 143±12 (p<0.01) Group D pre 105±12 vs 823±20 (p<0.00001) Group E pre 36±12 vs 83±10 (p<0.01) In contrast, Lp(a) levels in Group B were significantly reduced (135±12 vs. 117±10 mg/L, p<0.05) after treatment. Conclusions: Administration of the above mentioned antibiotics for 10 days resulted in a significant elevation of Lp(a) levels except those who underwent cefaclor treatment. The latter seemed to reduce Lp(a) levels when administrated for the same time. Much attention must be paid on patients on chronic administration of the above mentioned antibiotics. In contrast, cefaclor administration may be used as an Lp(a) reducing drug.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gavrili, Stavroula
- Γαβρίλη, Σταυρούλα
Subjects
dc:subject × 20- Λιποπρωτεΐνη (α)
- Κεφακλόρη
- Λορακαρμπέφη
- Αμοξικιλλίνη
- Κλαβουλανικό οξύ
- Τριμεθοπρίμη
- Σουλφαμεθοξαζόλη
- Κλαριθρομυκίνη
- Lipoprotein (α)
- Cefaclor
- Loracarbef
- Amoxicillin
- Clavulanic acid
- Trimethoprim
- Sulfamethoxazole
- Clarithromycin
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21069